WO2026028053 - PROCESS FOR THE PREPARATION OF TOVORAFENIB
National phase entry is expected:
Publication Number
WO/2026/028053
Publication Date
05.02.2026
International Application No.
PCT/IB2025/057575
International Filing Date
25.07.2025
Title **
[English]
PROCESS FOR THE PREPARATION OF TOVORAFENIB
[French]
PROCÉDÉ DE PRÉPARATION DE TOVORAFÉNIB
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
NAIKADE, Niraj
JAISWAL, Sanjay
KUMAR, Sumit
HAJKÓ, János
CSORVÁSI, Gizella Andrea
BÁNÓCZI, Gergely
PAÁL, Tihamér
RÁCZ, Dávid
SÓS, Martin
Priority Data
202411057163
27.07.2024
IN
202411078240
15.10.2024
IN
202511042342
01.05.2025
IN
202511057249
14.06.2025
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3778 | |
| EPO | Filing, Examination, Granting | 39846 | |
| Japan | Filing, Examination, Granting | 3569 | |
| South Korea | Filing, Examination, Granting | 4928 | |
| USA | Filing, Examination, Granting | 20540 |
Total:
72,661
Contact Us
Abstract[English]
The present disclosure relates to safe and efficient processes for the synthesis of Tovorafenib.[French]
La présente divulgation concerne des procédés sûrs et efficaces destinés à la synthèse du Tovorafénib.